News

Millennium Laboratories Expands Pharmacogenetic Test to Help Clinicians Prescribe the Right Medicine at the Right Dose

Millennium PGT helps clinicians make individualized medication decisions

SAN DIEGO (July 17, 2014) — Millennium Laboratories announced today that it has expanded its pharmacogenetic test (Millennium PGTSM) to include seven additional genes. The expanded test gives clinicians additional, objective information, based on patients’ own genetics to help determine their potential response to a broad list of medications commonly prescribed across four key therapeutic areas, including pain, mental health, addiction and cardiovascular therapy. More

Harvard Business Review: Health Care Becomes Entrepreneurial (Finally)

In a recent post in a leading national business strategy publication, Harvard Business Review blog authors Sachin Jain and Thomas Tsang examine recent trends in health care innovation, citing Millennium Laboratories’ subsidiary RxAnte on the forefront. More

Local Children to Benefit from Millennium Laboratories’ Commitment to Big Brothers Big Sisters of San Diego County

Corporate Social Responsibility and Volunteerism a Top Priority for Local Company

SAN DIEGO (May 14, 2014) – Millennium Laboratories, a leader in the science of medication monitoring and pharmacogenetics, announced today that it has partnered with Big Brothers Big Sisters of San Diego County. More

Millennium Laboratories Announces Key Executive Appointments For Commercial Operations

Seasoned Marketing, Sales and Compliance Leaders Added to Management Team

SAN DIEGO (May 5, 2014) – Millennium Laboratories, a leader in the science of medication monitoring and pharmacogenetics, today announced it has hired Nikhil A. Nayak as chief marketing officer; Steven K. Soe as chief compliance officer; and Michael E. Flowers as vice president, government operations. More

Clinical Study Shows Lab-based Urine Drug Monitoring, Interventions Improve Outcomes for Injured Workers on Chronic Opioid Therapy

High-risk Medication Utilization, Abuse Reduced

Memphis, Tenn. and San Diego, Calif. (April 24, 2014) — Clinical interventions performed in conjunction with laboratory quantitative drug testing and monitoring were shown to reduce utilization of high risk medications in injured workers on chronic opioid therapy, according to a clinical study released by the merged entity of Progressive Medical and PMSI, in partnership with Millennium Laboratories. More

Millennium Laboratories and RxAnte Link Strategic Advisory Boards

Advisors include industry experts, such as Former Senate Majority Leader Tom Daschle and former CMS Administrator Dr. Mark McClellan, with goal of advancing medication management

SAN DIEGO (April 3, 2014)– Millennium Laboratories announced today that it has established an advisory board consisting of distinguished health care, technology and public policy experts to provide strategic guidance to the company. More

Millennium Labs Helps Launch Coalition to Tackle Prescription Drug Misuse, Abuse in San Diego

Initial focus is thefts at real estate open houses

SAN DIEGO (March 11, 2014) – The Greater San Diego Association of REALTORS®, local nonprofits, Millennium Laboratories, and other partners announced today the formation of the Safe Homes Coalition that will work to inform people about the proper use, storage and disposal of prescription drugs. More

Massachusetts Federal Court Again Dismisses Whistleblower Lawsuit Against Millennium Laboratories

Millennium, gratified by the final ruling, continues to lead industry initiatives to implement higher compliance standards and ethical business practices

SAN DIEGO (Jan. 30, 2014)— U.S. District Judge Rya Zobel ordered the complete dismissal of a whistleblower suit brought by a former Calloway Laboratories’ senior officer against Millennium Laboratories, a leader in the science of medication monitoring and pharmacogenetic testing. More

Millennium Laboratories Announces Strategic Acquisition of RxAnte

Advanced analytics technology adds population drug therapy management and predictive capabilities to medication monitoring and pharmacogenetics for optimizing medication outcomes.

SAN DIEGO and McLEAN, VA. (Jan. 13, 2014) —Millennium Laboratories, a leader in the science of medication monitoring and pharmacogenetic testing, announced today its acquisition of RxAnte, a health care predictive analytics and decision support company that improves population-level medication adherence on behalf of health plans, pharmacy benefit management companies, pharmacy chains, and health care providers. More

Sovereign Health Group Announces Use of Millennium PGTSM in Psychiatric Treatment

Sovereign Health Group, a California-based behavioral health company, announced the utilization of Millennium PGT to assess the effectiveness of medication in the treatment of psychiatric disorders. More

Millennium Laboratories Delivers Comfort, Security, and Joy to San Diego Foster Children and Children in Need

Local company delivers 15,000 stuffed animals to San Diego County at Polinsky Children’s Center

SAN DIEGO (Dec. 17, 2013)—Millennium Laboratories, a leader in the science of toxicology and pharmacogenetics, delivered 15,000 stuffed animals to San Diego County’s foster children and at risk youth at an event on Monday at the Polinsky Children’s Center in Kearny Mesa, Calif. More

Media Contacts:

Nicole Beckstrand

Millennium Laboratories
O: (858) 217-1192
Nicole.Beckstrand@millenniumlabs.com

Joe St. Martin

Waggener Edstrom
O: (503) 443-7162
jstmartin@waggeneredstrom.com